homocysteine has been researched along with Hypercoagulability in 132 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 18 (13.64) | 18.2507 |
2000's | 81 (61.36) | 29.6817 |
2010's | 29 (21.97) | 24.3611 |
2020's | 4 (3.03) | 2.80 |
Authors | Studies |
---|---|
Margolin, E; Nicholson, P; Patel, TJ; Zaslavsky, K | 1 |
Al-Jamea, LH; Al-Maqati, T; Al-Mulhim, A; Aldarmahi, A; Aldossary, MA; Alnaam, Y; Alzahrani, FM; Elnagi, E; Hassan, FM; Shaikh, SS | 1 |
Cho, S; Lee, JS | 1 |
Callebert, J; Drouet, L; Eliezer, M; Hautefort, C; Kania, R; Launay, JM; Siguret, V; Stepanian, A; Vitaux, H; Vodovar, N | 1 |
Denecke, J | 1 |
Armstrong, EM; Bellone, JM; Hornsby, LB; Phillippe, HM; Treadway, S | 1 |
Akar, N; Delibaş, N; Ergürhan İlha, I; Kişioğlu, N; Köroğlu, M; Sütçü, R; Türedi Yildirim, A | 1 |
Irkec, M; Mocan, MC; Orhan, M; Sekeroglu, MA | 1 |
Friedman, J; Glueck, CJ; Hafeez, A; Hassan, A; Wang, P | 1 |
Gandhi, N; Glueck, CJ; Hemachandra, K; Shah, P; Smith, D; Wang, P | 1 |
Hernández, JL; Napal, JJ; Neila, S; Pérez-Montes, R; Ruiz, S; Sierra, I | 1 |
Freiberg, RA; Glueck, CJ; Jetty, V; Wang, P | 1 |
Spence, JD | 1 |
Adachi, T; Kobayashi, Y; Ochi, A | 1 |
Amaral, FM; Daldegan, MB; Grisolia, CK; Lordelo, GS; Miranda-Vilela, AL; Ribeiro, IF | 1 |
Corella, D; Ferrando, F; Gómez, I; Mira, Y; Vayá, A | 1 |
Davis, MR; Long, JN; Marques, M; Shell, DH | 1 |
Benedetto, C; Facchinetti, F; Frusca, T; Grandone, E; Marozio, L; Tiscia, GL; Venturini, P; Zatti, S | 1 |
Abbate, R; Fedi, S; Giambene, B; Marcucci, R; Menchini, U; Prisco, D; Sodi, A; Sofi, F | 2 |
Akar, N; Deda, G; Ertem, M; Teber, S; Unal, O | 1 |
Cirocchi, R; Farinella, E; La Mura, F; Sciannameo, F | 1 |
Agrawal, S; Baburaj, VP; Sankhwar, SN; Sharma, RK; Tripathi, G | 1 |
Koek, G; Peeters, L; Sep, S; Smits, L; Spaanderman, M; Verbeek, J | 1 |
Criado, PR; Di Giacomo, TB; Hussein, TP; Souza, DG | 1 |
Amato, A; Cini, M; Conti, E; Favaretto, E; Legnani, C; Palareti, G; Sartori, M | 1 |
Abbas, O; El-Gohary, GM; Eweda, II; Nammas, W; Samir, S | 1 |
Chuchin, MIu; Komarova, IB; Netesova, EV; Ushakova, LV; Vasil'ev, SA; Zykov, VP | 1 |
Antonakos, G; Armaganidis, A; Bagos, P; Dima, K; Dimopoulou, I; Kapsimali, V; Kopterides, P; Nikolopoulos, G; Travlou, A; Tsangaris, I; Tsantes, A; Vrioni, G | 1 |
Abraldes, JG; Candusso, M; Luciani, M; Monti, L; Nobili, V; Pancotti, S; Pietrobattista, A; Soldati, M; Torre, G | 1 |
Celen, S; Danisman, N; Dogan, OO; Simsek, Y | 1 |
Kirschner, J; Meinicke, H; Moske-Eick, O; Sitzberger, AN; Zieger, B | 1 |
Calcaterra, V; de Silvestri, A; Gamba, G; Lanati, G; Larizza, D; Montani, N; Terulla, V | 1 |
Conti, E; Favaretto, E; Frascaro, M; Legnani, C; Palareti, G; Sartori, M | 1 |
Finkelstein, SA; Rennicks White, R; Rodger, M; Shachkina, S; Smith, GN; Walker, MC; Wen, SW | 1 |
Ben Hamouda, H; Braham, H; Ghanmi, S; Hamza, HA; Hassine, M; Sfar, MT; Soua, H; Wannes, S | 1 |
Ardizzone, S; Bolzacchini, E; de Franchis, R; Dell'Era, A; Maconi, G; Russo, U | 1 |
Bern, M; McCarthy, N | 1 |
Deng, F; Guo, X; Hao, Y; Huang, J; Qin, Y; Shima, M; Wang, H; Wang, X; Wei, H; Wu, S; Zheng, C | 1 |
Ashraf, MZ; Behari, M; Chatterjee, T; Choudhry, VP; Gupta, N; Saxena, R | 1 |
Adamek, L; Domagala, TB; Nizankowska, E; Sanak, M; Szczeklik, A | 1 |
Choi, SW; Choi, YM; Kang, SW; Lee, EB; Lee, YJ; Sheen, D; Song, YW; Yang, JI | 1 |
Gala, JL; Hainaut, P; Heusterspreute, M; Jaumotte, C; Lavenne, E; Moriau, M; Verhelst, D; Wallemacq, P; Zech, F | 1 |
Calvo, MT; García-Erce, JA; Giralt Raichs, M; Grasa Ullrich, JM; Marcuello Melendo, B; Sánchez-Marín, B; Torres Gómez, M | 1 |
Ghitescu, L; Gugliucci, A | 1 |
McLaughlin, MA; Nguyen, VH | 1 |
Key, NS; McGlennen, RC | 1 |
O'Donnell, J; Perry, DJ | 1 |
Ames, PR; Amitrano, L; Annunziata, M; Antinolfi, I; Balzano, A; Brancaccio, V; Ferrara, F; Guardascione, MA; Iannaccone, L; Margaglione, M | 1 |
Adeleine, P; Berruyer, M; Cakmak, S; Derex, L; Froment, JC; Hermier, M; Nighoghossian, N; Philippeau, F; Trouillas, P | 1 |
Favier, A; Galan, P; Guilland, JC; Hercberg, S; Potier de Courcy, G | 1 |
Blann, A; Lip, GY; Nadar, S | 1 |
Arya, R; Asonganyi, B; Ford, E; Jackson, SH; Mangoni, AA; Ouldred, E; Sherwood, RA; Swift, CG | 1 |
Kubicka-Trzaska, A; Undas, A | 1 |
Cucinotta, D; Russo, GT | 1 |
Cobelli, M; Marietta, M; Panini, R; Rosa, MC; Salvioli, G; Ventura, P | 1 |
Aydin, B; Gürelik, G; Hasanreisoğlu, B; Ozdek, S; Yülek, F | 1 |
Houston, DS; Zarychanski, R | 1 |
Cappucci, F; Cittadini, E; Colaizzo, D; Grandone, E; Lo Bue, A; Margaglione, M; Vecchione, G; Vergura, P | 1 |
Antoniou, P; Kouroumalis, EA; Koutroubakis, IE; Malliaraki, N; Romanos, J; Samonakis, DN; Sfiridaki, A | 1 |
Alexander, M; Gnanamuthu, C; Joseph, M; Vaid, U | 1 |
Al Kawi, A; Kattah, JC; Kishore, K; Wang, DZ | 1 |
Bank, I; Büller, HR; Hamulyák, K; Koopman, MM; Libourel, EJ; Middeldorp, S; Prins, MH; van de Poel, MH; van der Meer, J | 1 |
Ghosh, K; Khare, A; Kulkarni, B; Mohanty, D; Shetty, S | 1 |
Kotel'nikov, MV | 1 |
Darioli, R; Mathez, Ch; Trueb, L; Waeber, G | 1 |
Bots, ML; Bruinse, HW; Fijnheer, R; Franx, A; Krabbendam, I | 1 |
Favaloro, EJ | 1 |
Tripodi, A | 1 |
Marpeau, L; Verspyck, E | 1 |
Abbate, R; Dorigo, W; Gensini, GF; Lari, B; Marcucci, R; Pratesi, C; Pratesi, G; Prisco, D; Rogolino, A; Sofi, F | 1 |
Ganesan, V; Haywood, S; Liesner, R; Pindora, S | 1 |
Almasy, L; Blanco-Vaca, F; Blangero, J; Buil, A; Fontcuberta, J; Lathrop, M; Martín-Campos, JM; Ordoñez-Llanos, J; Soria, JM; Souto, JC; Stone, W | 1 |
Abbate, R; Alessandrello Liotta, A; Berloco, P; Cellai, AP; Leprini, E; Marcucci, R; Pagnini, P; Prisco, D; Rogolino, A | 1 |
Ely, SF | 1 |
Abbate, R; Brogi, D; Gensini, GF; Giglioli, C; Gori, AM; Lenti, M; Liotta, AA; Marcucci, R; Prisco, D; Sofi, F; Valente, S | 1 |
Caprini, JA; Glase, CJ; Goldshteyn, S; Hathaway, K | 1 |
Fields, MC; Levine, SR | 1 |
Chen, TW; Lin, CC; Tai, HC; Yang, WC | 1 |
Dávid, M; Habon, T; Keszthelyi, Z; Kovács, N; Losonczy, H; Nagy, A; Tóth, O | 1 |
Abbate, R; Gensini, GF; Giusti, B; Lari, B; Lo Sapio, P; Marcucci, R; Pratesi, C; Pratesi, G; Pulli, R; Sestini, I; Sofi, F | 1 |
Al Haddabi, H; Al Kindi, S; Bayoumi, R; Dennison, D; Muralitharan, S; Pathare, A | 1 |
Abbate, R; Biagini, MR; Capanni, M; Ceni, E; Fedi, S; Galli, A; Manta, R; Marcucci, R; Milani, S; Paniccia, R; Surrenti, C; Tozzi, A | 1 |
Candito, E; Candito, M; Chatel, M; Dunac, A; Lapoussiere, M; Mengual, R; Van Obberghen, E | 1 |
Aznar, J; Calvo, J; Corella, D; España, F; Estellés, A; Ricart, JM; Santaolaria, M; Todolí, J; Vayá, A; Villa, P | 1 |
Blom, HJ; Bos, GM; Cattaneo, M; den Heijer, M; Eichinger, S; Gerrits, WB; Rosendaal, FR; Willems, HP | 1 |
Cattaneo, M | 2 |
Candito, E; Candito, M; Chatel, M; Dunac, A; van Obberghen, E | 1 |
Latella, C; Lombardo, VT; Luise, F; Mammi, C; Occhiuto, A; Oriana, V; Piromalli, A; Ramirez, F; Sottilotta, G | 1 |
Abbate, R; Falciani, M; Giambene, B; Liotta, AA; Mannini, L; Marcucci, R; Menchini, U; Poli, D; Prisco, D; Sodi, A | 1 |
Varga, E | 1 |
Abbate, R; Gensini, GF; Gori, AM; Marcucci, R; Sofi, F | 1 |
Papadimitriou, DK; Pitoulias, GA; Tachtsi, MD; Tsiaousis, PZ | 1 |
Abaci, N; Arseven, O; Diz-Kucukkaya, R; Issever, H; Kiyan, E; Okumus, G; Tabak, L; Unaltuna, NE; Unlucerci, Y | 1 |
Abdella, NA; Al Humood, S; Al Shayeb, AR; Al Wazzan, H; El-Muzaini, H; Marouf, R; Mojiminiyi, OA; Qurtom, M; Samad, MA | 1 |
Bernardi, F; Coccheri, S; Ferraresi, P; Grauso, F; Grossi, G; Legnani, C; Marchetti, G; Palareti, G; Piazzi, S; Sassi, S | 1 |
Blom, HJ; Boers, GH; Kluijtmans, LA; Novakova, IR; Trijbels, FJ; Verbruggen, B | 1 |
Bielenberg, J | 1 |
Hall, TN | 1 |
de Swiet, M; Girling, J | 1 |
Abbate, R; Camacho Vanegas, O; Giusti, B; Pepe, G; Restrepo Fernandez, CM | 1 |
Francis, JL | 1 |
McDowell, IF; Still, RA | 1 |
Bergman, SM; Morgan, SL; Tamura, T | 1 |
Blair, AJ; Dumenco, LL; Sweeney, JD | 1 |
Arroliga, AC; Marelich, GP; Matthay, RA; Murin, S | 1 |
Alatri, A; Franchi, F; Moia, M | 1 |
Cattaneo, M; Lecchi, A; Lombardi, R; Zighetti, ML | 1 |
Bostom, AG; Selhub, J | 1 |
Sacher, RA | 1 |
Ridker, PM | 1 |
Backhouse, O; Lee, D; Mahomed, I; Parapia, L | 1 |
Cerbone, AM; Coppola, A; D'Angelo, A; Fermo, I; Galli, L; Madonna, P; Mazzola, G; Pagano, A | 1 |
Hunter, AG | 1 |
Perry, DJ | 1 |
Abbate, R; Brunelli, T; Capanni, M; Federici, G; Fedi, S; Gensini, GF; Gori, AM; Marcucci, R; Pastore, A; Pepe, G; Prisco, D; Simonetti, I | 1 |
Coppola, A; Di Minno, G; Mancini, FP; Margaglione, M | 1 |
Blom, HJ | 1 |
Cerbone, AM; Coppola, A; Davi, G; De Stefano, V; Di Minno, G; Mancini, FP | 1 |
Bos, GM; den Heijer, M; Willems, HP | 1 |
Robinson, K; van Guldener, C | 1 |
Boers, GH; Naughten, ER; Wilcken, B; Wilcken, DE; Yap, S | 1 |
Bek, T; Hansen, L; Ingerslev, J; Kristensen, HL | 1 |
Brown, WV | 1 |
Friedler, S; Kornberg, Y; Raziel, A; Ron-El, R; Schachter, M; Sela, BA | 1 |
Chang, CJ; Chiang, CW; Hsu, LA; Hsu, TS; Ko, YL; Kuo, CT; Lee, YS; Sun, CF | 1 |
Abu-Hajir, M; Berger, WL; Binion, DG; Emmons, J; Saiean, K; Seetharam, B; Vasilopoulos, S | 1 |
Ames, PR; Cappucci, G; Margaglione, M | 1 |
Ames, PR; Bossone, A; Brancaccio, V; Iannaccone, L; Margaglione, M; Tommasino, C | 1 |
Johnson, RN; Kearney, J; Koo, H; Lahey, JM; Modlinski, B; Tanaka, S; Tunç, M | 1 |
Cattaneo, M; Chantarangkul, V; Mannucci, PM; Tripodi, A; Zighetti, ML | 1 |
31 review(s) available for homocysteine and Hypercoagulability
Article | Year |
---|---|
The association of thrombophilia in women with severe obstetric complications.
Topics: Female; Homocysteine; Humans; Mass Screening; Pregnancy; Pregnancy Complications; Risk Factors; Thrombophilia | 2022 |
Inherited Thrombophilia.
Topics: Hemostasis; Homocysteine; Humans; Mutation; Thrombophilia; Thrombosis; Venous Thromboembolism; Vitamin B Complex | 2014 |
Coronary artery disease in women: a review of emerging cardiovascular risk factors.
Topics: Anticholesteremic Agents; Biomarkers; Coronary Disease; Female; Homocysteine; Humans; Hyperlipidemias; Lipoprotein(a); Oxidative Stress; Risk Factors; Thrombophilia; Women's Health | 2002 |
Hyperhomocyst(e)inemia and Thrombophilia.
Topics: Blood Coagulation Tests; Homocysteine; Humans; Hyperhomocysteinemia; Practice Guidelines as Topic; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Thromboembolism; Thrombophilia; Venous Thrombosis | 2002 |
Pharmacotherapy of hyperhomocysteinaemia in patients with thrombophilia.
Topics: Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Methionine; Pyridoxine; Renal Insufficiency; Thrombophilia; Vitamin B 12; Vitamins | 2002 |
[Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease?. 1. Basic data].
Topics: Animals; Arteriosclerosis; Biomarkers; Cystathionine beta-Synthase; Folic Acid Deficiency; Genetic Predisposition to Disease; Homocysteine; Homocystinuria; Humans; Hyperhomocysteinemia; Methionine; Methylation; Methylenetetrahydrofolate Reductase (NADPH2); Models, Biological; Nitric Oxide; Oxidative Stress; Oxidoreductases Acting on CH-NH Group Donors; Rats; Risk Factors; S-Adenosylmethionine; Signal Transduction; Thrombophilia; Vascular Diseases; Vasodilation; Vitamin B 6 Deficiency | 2003 |
[Thrombophilia as a risk factor for central retinal vein occlusion].
Topics: Antibodies, Antiphospholipid; Diabetes Complications; Factor V; Homocysteine; Humans; Hypercholesterolemia; Hypertension; Lipoprotein(a); Plasminogen Activator Inhibitor 1; Retinal Vein Occlusion; Risk Factors; Thrombophilia | 2003 |
[Hyperhomocysteinemia and cardiovascular risk in diabetes mellitus].
Topics: Adult; Arteriosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Angiopathies; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Risk Factors; Thrombophilia | 2003 |
[Hyperhomocysteinemia: from theory and practice in the treatment of thrombophilias].
Topics: Administration, Oral; Anticoagulants; Blood Coagulation Tests; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Marfan Syndrome; Multicenter Studies as Topic; Mutation; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Risk Factors; Thrombophilia; Time Factors; Venous Thrombosis; Vitamin B 12; Vitamin B 6 | 2004 |
Thrombophilias and recurrent pregnancy loss: a critical appraisal of the literature.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Factor V; Female; Gestational Age; Homocysteine; Humans; Mutation; Odds Ratio; Pregnancy; Protein C; Prothrombin; Thrombophilia | 2005 |
A review of the clinical and diagnostic utility of laboratory tests for the detection of congenital thrombophilia.
Topics: Activated Protein C Resistance; Antithrombins; Chemistry, Clinical; Factor V; Fibrinogens, Abnormal; Genotype; Hematology; Homocysteine; Humans; Mutation; Protein C; Protein S; Prothrombin; Reproducibility of Results; Thrombophilia | 2005 |
[Thrombophilias and vascular placental pathology. A survey of the literature].
Topics: Activated Protein C Resistance; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Cohort Studies; Confidence Intervals; Drug Therapy, Combination; Female; Fetal Death; Fetal Growth Retardation; Forecasting; Homocysteine; Humans; Infant, Newborn; Meta-Analysis as Topic; Multivariate Analysis; Odds Ratio; Placenta; Placenta Diseases; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Prospective Studies; Retrospective Studies; Risk Factors; Thrombophilia; Thrombosis | 2005 |
Thrombophilia and first arterial ischaemic stroke: a systematic review.
Topics: Brain Ischemia; Case-Control Studies; Chi-Square Distribution; Child; Factor V; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Odds Ratio; Prognosis; Thrombophilia | 2005 |
[Type I antithrombin deficiency as a cause of arterial and venous thrombosis in a family with severe thrombophilia].
Topics: Adult; C-Reactive Protein; Cholesterol; Cysteine; Female; Fibrin; Genetic Predisposition to Disease; Homocysteine; Humans; Male; Pedigree; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Risk Factors; Threonine; Thrombophilia; Thrombosis; Venous Thrombosis; von Willebrand Factor | 2005 |
Hyperhomocysteinemia and venous thromboembolism.
Topics: Case-Control Studies; Homocysteine; Homocystinuria; Humans; Hyperhomocysteinemia; Methylenetetrahydrofolate Reductase (NADPH2); Point Mutation; Prospective Studies; Recurrence; Risk Factors; Thromboembolism; Thrombophilia; Venous Thrombosis; Vitamins | 2006 |
Inherited thrombophilia: key points for genetic counseling.
Topics: Abortion, Habitual; Antithrombin III Deficiency; Factor V; Female; Genetic Counseling; Genetic Predisposition to Disease; Genetic Testing; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic; Pregnancy; Prothrombin; Referral and Consultation; Risk Assessment; Thromboembolism; Thrombophilia | 2007 |
[Thrombosis caused by estrogens. Genetic predisposition or induced by biochemical metabolic processes?].
Topics: Contraceptives, Oral, Hormonal; Estradiol Congeners; Factor V; Female; Germany; Homocysteine; Humans; Risk Factors; Thrombophilia | 1997 |
Inherited thrombophilia and pregnancy.
Topics: Biomarkers; Female; Homocysteine; Humans; Pregnancy; Pregnancy Complications; Protein C; Risk; Risk Factors; Thrombophilia | 1998 |
Laboratory investigation of hypercoagulability.
Topics: Afibrinogenemia; Antiphospholipid Syndrome; Antithrombins; Blood Coagulation Tests; Factor V; Fibrinolysis; Homocysteine; Humans; Lipoproteins; Lupus Coagulation Inhibitor; Monocytes; Platelet Activation; Protein C; Protein S; Protein S Deficiency; Prothrombin; Thrombomodulin; Thrombophilia; Thromboplastin | 1998 |
ACP Broadsheet No 152: March 1998. Clinical implications of plasma homocysteine measurement in cardiovascular disease.
Topics: Arteriosclerosis; Biomarkers; Blood Specimen Collection; Chromatography; Chromatography, High Pressure Liquid; Homocysteine; Humans; Risk Factors; Thrombophilia | 1998 |
Hereditary thrombophilia and venous thromboembolism.
Topics: Antithrombin III Deficiency; Factor V; Genetic Predisposition to Disease; Homocysteine; Humans; Mutation; Prevalence; Protein C; Protein C Deficiency; Protein S Deficiency; Prothrombin; Thrombophilia; Venous Thrombosis | 1998 |
Hyperhomocysteinemia, atherosclerosis and thrombosis.
Topics: Adult; Aged; Animals; Arteriosclerosis; Avitaminosis; Case-Control Studies; Clinical Trials as Topic; Cohort Studies; Cross-Sectional Studies; Cystathionine beta-Synthase; Female; Folic Acid; Gene Frequency; Homocysteine; Homocystinuria; Hormone Replacement Therapy; Humans; Hyperhomocysteinemia; Male; Methionine; Methylation; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Muscle, Smooth, Vascular; Oxidoreductases Acting on CH-NH Group Donors; Prevalence; Primates; Prospective Studies; Pyridoxine; Risk Factors; Smoking; Tamoxifen; Thrombophilia; Thrombosis; Vitamin B 12 | 1999 |
Thrombophilia: a genetic predisposition to thrombosis.
Topics: Activated Protein C Resistance; Antithrombins; Fibrinolysis; Homocysteine; Humans; Mutation; Protein C Deficiency; Protein S Deficiency; Prothrombin; Risk Factors; Thromboembolism; Thrombophilia; Thrombosis | 1999 |
Novel risk factors and markers for coronary disease.
Topics: Biomarkers; C-Reactive Protein; Coronary Disease; Fibrinogen; Fibrinolysis; Homocysteine; Humans; Hyperhomocysteinemia; Lipoprotein(a); Risk Factors; Thrombophilia; Vasculitis | 2000 |
Hyperhomocysteinaemia.
Topics: Animals; Dietary Supplements; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Pregnancy; Risk Factors; Thrombophilia; Thrombosis; Vascular Diseases; Vitamin B Complex | 1999 |
Homocysteine, platelet function and thrombosis.
Topics: Arterial Occlusive Diseases; Blood Coagulation Factors; Blood Platelets; Comorbidity; Endothelium, Vascular; Fibrinolysis; Free Radicals; Genetic Predisposition to Disease; Homocysteine; Homocystinuria; Humans; Hyperhomocysteinemia; Nitric Oxide; Oxidative Stress; Thrombin; Thrombomodulin; Thrombophilia; Thromboxane A2 | 1999 |
Consequences of homocysteine export and oxidation in the vascular system.
Topics: Arteriosclerosis; Blood Cells; Cardiovascular System; Disulfides; Endothelium, Vascular; Genetic Predisposition to Disease; Homocysteine; Humans; Hyperhomocysteinemia; Kidney; Liver; Oxidation-Reduction; Thrombophilia | 2000 |
Homocysteine, coagulation, platelet function, and thrombosis.
Topics: Adolescent; Adult; Arteriosclerosis; Blood Coagulation; Cardiovascular Diseases; Cellular Senescence; Child; Endothelium, Vascular; Female; Genetic Predisposition to Disease; Homocysteine; Homocystinuria; Humans; Hyperhomocysteinemia; Lipid Peroxidation; Lipoproteins, LDL; Male; Methyltransferases; Oxidation-Reduction; Platelet Activation; Reactive Oxygen Species; Renal Insufficiency; Risk Factors; S-Adenosylhomocysteine; Thrombophilia; Thromboxane B2; Vitamin K | 2000 |
Homocysteine and renal disease.
Topics: Adult; Arteriosclerosis; Cardiovascular Diseases; Case-Control Studies; Child; Endothelium, Vascular; Female; Folic Acid; Folic Acid Deficiency; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Diseases; Kidney Failure, Chronic; Kidney Transplantation; Life Tables; Male; Methionine; Peritoneal Dialysis; Prospective Studies; Pyridoxine; Renal Dialysis; Survival Analysis; Thrombophilia; Vitamin B 12; Vitamin B 12 Deficiency; Vitamin B 6 Deficiency | 2000 |
Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy.
Topics: Adolescent; Adult; Aged; Australia; Child; Child, Preschool; Cohort Studies; Cystine; Drug Resistance; Female; Folic Acid; Follow-Up Studies; Genetic Predisposition to Disease; Homocysteine; Homocystinuria; Humans; Hyperhomocysteinemia; Infant; Ireland; Male; Methionine; Middle Aged; Netherlands; Pyridoxine; Risk; Risk Factors; Thrombophilia; Vascular Diseases; Vitamin B 12 | 2000 |
Risk factors for vascular disease in patients with diabetes.
Topics: Diabetic Angiopathies; Homocysteine; Humans; Hyperglycemia; Hyperlipidemias; Hypertension; Insulin Resistance; Models, Cardiovascular; Obesity; Risk Factors; Smoking; Thrombophilia | 2000 |
4 trial(s) available for homocysteine and Hypercoagulability
Article | Year |
---|---|
Cerebral venous thrombosis: clinical outcome and systematic screening of prothrombotic factors.
Topics: Adult; Anticoagulants; Cerebral Angiography; Disability Evaluation; Factor VIII; Female; Heparin; Homocysteine; Humans; Intracranial Thrombosis; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Mass Screening; Thrombophilia; Time Factors; Treatment Outcome | 2003 |
Effects of folic acid supplementation on inflammatory and thrombogenic markers in chronic smokers. A randomised controlled trial.
Topics: Adult; Biomarkers; Blood Proteins; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Folic Acid; Homocysteine; Humans; Inflammation; International Normalized Ratio; Male; Middle Aged; Partial Thromboplastin Time; Smoking; Thrombophilia; Treatment Outcome | 2003 |
Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: A randomized, placebo-controlled, double-blind trial.
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Proportional Hazards Models; Pulmonary Embolism; Pyridoxine; Recurrence; Risk Factors; Thrombophilia; Treatment Failure; Venous Thrombosis; Vitamin B 12 | 2007 |
Homocysteine and venous thrombosis: outline of a vitamin intervention trial.
Topics: Adult; Aged; Aged, 80 and over; Comorbidity; Double-Blind Method; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Male; Middle Aged; Netherlands; Prospective Studies; Pulmonary Embolism; Pyridoxine; Retrospective Studies; Secondary Prevention; Thrombophilia; Thrombophlebitis; Treatment Outcome; Ultrasonography; Venous Thrombosis; Vitamin B 12 | 2000 |
97 other study(ies) available for homocysteine and Hypercoagulability
Article | Year |
---|---|
Hypercoagulability in patients with indirect carotid cavernous fistulas.
Topics: Antibodies, Anticardiolipin; Antithrombin III; Atrial Fibrillation; Female; Fibrinogen; Fistula; Homocysteine; Humans; Lupus Coagulation Inhibitor; Male; Protein C; Prothrombin; Thrombophilia | 2022 |
Methylene tetrahydrofolate reductase C677T polymorphism in Korean livedoid vasculopathy patients.
Topics: Adolescent; Adult; Case-Control Studies; Eczema; Female; Genetic Association Studies; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation, Missense; Point Mutation; Polymorphism, Single Nucleotide; Psoriasis; Republic of Korea; Retrospective Studies; Thrombophilia; Vasculitis; Young Adult | 2021 |
Plasma Serotonin is Elevated in Adult Patients with Sudden Sensorineural Hearing Loss.
Topics: Adult; Female; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Homocysteine; Humans; Male; Middle Aged; Serotonin; Thrombophilia | 2020 |
Testing for hyperhomocysteinemia in subjects with a history of thromboembolic events using HPLC technique.
Topics: Chromatography, High Pressure Liquid; Homocysteine; Humans; Hyperhomocysteinemia; Thromboembolism; Thrombophilia | 2013 |
The role of prothrombotic factors in children with hemiplegic cerebral palsy.
Topics: Adolescent; Case-Control Studies; Cerebral Palsy; Child; Child, Preschool; Female; Hemiplegia; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Thrombophilia | 2015 |
Hereditary Thrombophilic Factors in Glaucoma.
Topics: Activated Protein C Resistance; Aged; Aged, 80 and over; Antithrombin III; Blood Coagulation Factors; Case-Control Studies; Exfoliation Syndrome; Factor V; Female; Glaucoma, Open-Angle; Homocysteine; Humans; Intraocular Pressure; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Prospective Studies; Protein C; Protein S; Prothrombin; Risk Factors; Thrombophilia | 2016 |
Testosterone therapy, thrombophilia, and hospitalization for deep venous thrombosis-pulmonary embolus, an exploratory, hypothesis-generating study.
Topics: Homocysteine; Hormone Replacement Therapy; Humans; Immunoglobulin G; Immunoglobulin M; Male; Middle Aged; Models, Biological; Polymerase Chain Reaction; Pulmonary Embolism; Risk Factors; Testosterone; Thrombophilia; Thrombosis; Warfarin | 2015 |
Treatable high homocysteine alone or in concert with five other thrombophilias in 1014 patients with thrombotic events.
Topics: Female; Homocysteine; Humans; Male; Middle Aged; Thrombophilia; Thrombosis | 2015 |
The role of coagulation disorders in patients with retinal vein occlusion.
Topics: Aged; Antibodies, Antiphospholipid; Anticoagulants; Aspirin; Case-Control Studies; Female; Homocysteine; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prevalence; Prospective Studies; Retinal Vein Occlusion; Risk Factors; Spain; Thrombophilia | 2016 |
Venous Thromboembolism After Knee Arthroscopy in Undiagnosed Familial Thrombophilia.
Topics: Antibodies, Anticardiolipin; Antithrombin III Deficiency; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Arthroscopy; Blood Coagulation Factor Inhibitors; Blood Coagulation Factors; Factor V; Factor VIII; Factor XI; Female; Homocysteine; Humans; Knee Joint; Male; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Plasminogen Activator Inhibitor 1; Prothrombin; Thrombophilia; Venous Thromboembolism | 2016 |
Increased Coagulation With Aging: Importance of Homocysteine and Vitamin B12.
Topics: Adult; Aged; Aged, 80 and over; Aging; Atrial Fibrillation; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Thrombophilia; Vitamin B 12 | 2017 |
Increased Coagulation With Aging: Importance of Homocysteine and Vitamin B12 - Reply.
Topics: Aging; Homocysteine; Humans; Hyperhomocysteinemia; Thrombophilia; Vitamin B 12 | 2017 |
Interactions among methylenetetrahydrofolate reductase (MTHFR) and cystathionine β-synthase (CBS) polymorphisms - a cross-sectional study: multiple heterozygosis as a risk factor for higher homocysteine levels and vaso-occlusive episodes.
Topics: Adolescent; Adult; Brazil; Cross-Sectional Studies; Cystathionine beta-Synthase; Epistasis, Genetic; Female; Folic Acid; Gene Frequency; Genetic Predisposition to Disease; Genotype; Heterozygote; Homocysteine; Homozygote; Humans; Linkage Disequilibrium; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Risk Factors; Thrombophilia; Thrombosis; Vitamin B 12; Young Adult | 2017 |
Homocysteine levels in patients with deep vein thrombosis lacking thrombophilic defects.
Topics: Adult; Case-Control Studies; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Risk Assessment; Risk Factors; Thrombophilia; Venous Thrombosis | 2008 |
Free flap failure secondary to dual thrombophilia.
Topics: Factor VIII; Graft Survival; Homocysteine; Humans; Hyperhomocysteinemia; Leg; Male; Microsurgery; Middle Aged; Plastic Surgery Procedures; Postoperative Complications; Surgical Flaps; Thrombophilia; Thrombosis; Ultrasonography, Doppler | 2009 |
Maternal thrombophilia and the risk of recurrence of preeclampsia.
Topics: Antibodies, Anticardiolipin; Antithrombins; Birth Weight; Cohort Studies; Factor V; Female; Gestational Age; Homocysteine; Humans; Infant, Newborn; Infant, Small for Gestational Age; Lupus Coagulation Inhibitor; Methylenetetrahydrofolate Reductase (NADPH2); Pre-Eclampsia; Pregnancy; Prospective Studies; Protein C; Protein S; Prothrombin; Regression Analysis; Thrombophilia | 2009 |
Evaluation of traditional and emerging cardiovascular risk factors in patients with non-arteritic anterior ischemic optic neuropathy: a case-control study.
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Case-Control Studies; Dyslipidemias; Enzyme-Linked Immunosorbent Assay; Female; Folic Acid; Homocysteine; Humans; Hypertension; Lipoprotein(a); Male; Middle Aged; Optic Neuropathy, Ischemic; Risk Factors; Thrombophilia; Vitamin B 12; Vitamin B 6 | 2009 |
Thrombophilic risk factors in epileptic children treated with valproic Acid.
Topics: Adolescent; Anticonvulsants; Antithrombin III; Blood Coagulation Factors; Child; Child, Preschool; Epilepsy; Female; Fibrinogen; Homocysteine; Humans; Infant; Lipoprotein(a); Male; Protein C; Protein S; Prothrombin; Risk Factors; Thrombophilia; Valproic Acid | 2009 |
A case of infarction of small bowel caused by thrombophilia secondary to hyperhomocysteinaemia.
Topics: Abdomen; Homocysteine; Humans; Hyperhomocysteinemia; Infarction; Intestine, Small; Laparotomy; Male; Middle Aged; Thrombophilia; Ultrasonography | 2009 |
Role of thrombotic risk factors in end-stage renal disease.
Topics: 3' Untranslated Regions; Adult; Alleles; Amino Acid Substitution; Factor V; Female; Folic Acid; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation, Missense; Point Mutation; Prothrombin; Risk Factors; Thrombophilia; Vitamin B 12; Young Adult | 2010 |
Clinical differences between early-onset HELLP syndrome and early-onset preeclampsia during pregnancy and at least 6 months postpartum.
Topics: Adult; Eclampsia; Factor V; Female; Heart Rate; HELLP Syndrome; Homocysteine; Humans; Hypercholesterolemia; Hyperglycemia; Hypertension; Hypertriglyceridemia; Mutation; Obesity; Postpartum Period; Pre-Eclampsia; Pregnancy; Proteinuria; Prothrombin; Thrombophilia | 2010 |
Frequency of thrombophilia determinant factors in patients with livedoid vasculopathy and treatment with anticoagulant drugs--a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Anticardiolipin; Anticoagulants; Blood Coagulation Tests; Factor V; Female; Fibrinogen; Heparin; Homocysteine; Humans; Lupus Coagulation Inhibitor; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Prospective Studies; Protein C; Protein S; Prothrombin; Skin Diseases, Vascular; Thrombophilia; Warfarin; Young Adult | 2010 |
Thrombophilic risk factors and peripheral arterial disease severity.
Topics: Aged; Constriction, Pathologic; Disease Progression; DNA Mutational Analysis; Factor VIII; Female; Fibrinogen; Homocysteine; Humans; Ischemia; Lupus Coagulation Inhibitor; Male; Mutation; Peripheral Arterial Disease; Polymorphism, Genetic; Prothrombin; Risk Factors; Thrombophilia | 2010 |
Right heart thrombus-in-transit with pulmonary embolism in a patient with primary hypercoagulable state.
Topics: Biomarkers; Cardiopulmonary Bypass; DNA Mutational Analysis; Echocardiography, Transesophageal; Embolectomy; Factor V; Female; Heart Diseases; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Pulmonary Embolism; Thrombophilia; Thrombosis; Tomography, X-Ray Computed; Treatment Outcome; Up-Regulation | 2010 |
[Prothrombotic disturbances in children after ischemic stroke].
Topics: Adolescent; Blood Coagulation Factors; Child; Child, Preschool; Homocysteine; Humans; Infant; Polymorphism, Genetic; Prothrombin; Stroke; Thrombophilia | 2009 |
The effect of homocysteine on the clinical outcomes of ventilated patients with severe sepsis.
Topics: Activated Protein C Resistance; Aged; Blood Coagulation Tests; Cohort Studies; Comorbidity; Factor V; Female; Folic Acid; Homocysteine; Homocystinuria; Hospital Mortality; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Muscle Spasticity; Point Mutation; Protein C; Psychotic Disorders; Respiration, Artificial; Sepsis; Shock, Septic; Thrombophilia; Vitamin B 12 | 2010 |
Atherosclerotic and thrombophilic risk factors in patients with ischemic central retinal vein occlusion.
Topics: Acute Disease; Aged; Atherosclerosis; Biomarkers; Dyslipidemias; Factor VIII; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Ischemia; Male; Retinal Vein Occlusion; Risk Factors; Thrombophilia | 2011 |
Extrahepatic portal vein thrombosis in children and adolescents: Influence of genetic thrombophilic disorders.
Topics: Adolescent; Case-Control Studies; Child; Homocysteine; Humans; Male; Portal Vein; Prospective Studies; Protein C; Protein S; Risk Factors; Thrombophilia; Venous Thrombosis | 2010 |
Frequency of hereditary thrombophilia, anticoagulant activity, and homocysteine levels in patients with hemolysis, elevated liver functions and low thrombocyte count (HELLP) syndrome.
Topics: Adolescent; Adult; Antithrombin III; Blood Coagulation Factor Inhibitors; Blood Coagulation Factors; Female; HELLP Syndrome; Homocysteine; Humans; Pregnancy; Protein C; Protein S; Thrombophilia; Turkey; Young Adult | 2011 |
Anterior spinal artery syndrome in a 13-year-old boy 8 days after taekwondo-fight: vascular obliteration due to vessel lesion or thrombophilia?
Topics: Adolescent; Anterior Spinal Artery Syndrome; Arteries; Athletic Injuries; Diagnosis, Differential; Homocysteine; Humans; Male; Martial Arts; Methylenetetrahydrofolate Reductase (NADPH2); Neurologic Examination; Polymorphism, Genetic; Risk Factors; Spinal Cord; Sprains and Strains; Thrombophilia; Thrombosis; Wounds, Nonpenetrating | 2011 |
Thrombophilic screening in Turner syndrome.
Topics: Adolescent; Adult; Antithrombin III; Comorbidity; Factor VIII; Female; Fibrinogen; Genotype; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Protein C; Protein S; Prothrombin; Thromboembolism; Thrombophilia; Turner Syndrome; Young Adult | 2011 |
Thrombotic risk factors and cardiovascular events after endovascular intervention for peripheral arterial disease.
Topics: Aged; Angioplasty; Cardiovascular Diseases; Factor V; Factor VIII; Female; Fibrinogen; Homocysteine; Humans; Intermittent Claudication; Ischemia; Leg; Lupus Coagulation Inhibitor; Male; Peripheral Arterial Disease; Proportional Hazards Models; Risk Factors; Stents; Thrombophilia; Thrombosis | 2011 |
The Ottawa and Kingston (OaK) Birth Cohort: development and achievements.
Topics: Canada; Cohort Studies; Dietary Supplements; Female; Fetal Blood; Fetal Growth Retardation; Folic Acid; Gestational Age; Homocysteine; Humans; Infant, Newborn; Maternal Nutritional Physiological Phenomena; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Prenatal Care; Prospective Studies; Thrombophilia; Vitamins | 2011 |
[Neonatal renal vein thrombosis in a heterozygous carrier of both factor V Leiden and the MTHFR gene mutation].
Topics: Diagnosis, Differential; DNA Mutational Analysis; Factor V; Genetic Carrier Screening; Genetic Predisposition to Disease; Genetic Testing; Homocysteine; Homozygote; Humans; Infant, Newborn; Male; Methylenetetrahydrofolate Reductase (NADPH2); Renal Veins; Thrombophilia; Venous Thrombosis | 2012 |
Portal vein thrombosis in inflammatory bowel diseases: a single-center case series.
Topics: Adult; Anticoagulants; Colitis, Ulcerative; Crohn Disease; Female; Homocysteine; Humans; Lupus Coagulation Inhibitor; Male; Middle Aged; Portal Vein; Retrospective Studies; Risk Factors; Thrombophilia; Venous Thrombosis; von Willebrand Factor | 2012 |
Multiple markers of hypercoagulation in patients with history of venous thromboembolic disease.
Topics: Activated Protein C Resistance; Antibodies, Anticardiolipin; Antithrombin III; Biomarkers; Blood Coagulation Factors; Diagnostic Tests, Routine; Factor V; Homocysteine; Humans; Plasminogen Activator Inhibitor 1; Preoperative Care; Protein C; Recurrence; Retrospective Studies; Risk Factors; Thrombophilia; Venous Thromboembolism | 2013 |
Chemical constituents of ambient particulate air pollution and biomarkers of inflammation, coagulation and homocysteine in healthy adults: a prospective panel study.
Topics: Adult; Air Pollution; Biomarkers; Blood Coagulation; China; Cobalt; Environmental Exposure; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation Mediators; Male; Manganese; Nitrates; Particulate Matter; Prospective Studies; Thrombophilia; Urban Health; Vehicle Emissions; Zinc | 2012 |
Prediction of ischemic stroke in young Indians: is thrombophilia profiling a way out?
Topics: Adolescent; Adult; Antithrombin III; Brain Ischemia; Case-Control Studies; Female; Homocysteine; Humans; Hyperhomocysteinemia; India; Lupus Coagulation Inhibitor; Male; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic; Prognosis; Protein C; Protein C Deficiency; Protein S; Protein S Deficiency; Prothrombin; Stroke; Thrombophilia | 2013 |
Mutations C677T and A1298C of the 5,10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease.
Topics: 3' Untranslated Regions; Activated Protein C Resistance; Adolescent; Adult; Aged; Aged, 80 and over; Alleles; Amino Acid Substitution; Codon; Factor V; Fasting; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation, Missense; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Poland; Prothrombin; Risk Factors; Thrombophilia; Venous Thrombosis | 2002 |
Coagulation parameters and plasma total homocysteine levels in Behcet's disease.
Topics: Adult; Behcet Syndrome; Blood Coagulation; Blood Coagulation Factor Inhibitors; Blood Coagulation Factors; Case-Control Studies; Cross-Sectional Studies; Female; Homocysteine; Humans; Korea; Male; Plasminogen; Thrombophilia; Thrombosis | 2002 |
Hyperhomocysteinemia and venous thromboembolism: a risk factor more prevalent in the elderly and in idiopathic cases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Belgium; Case-Control Studies; Fasting; Female; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Prospective Studies; Protein C Deficiency; Pulmonary Embolism; Risk Factors; Thrombophilia; Venous Thrombosis | 2002 |
[C677TT mutation in methylentetrahydrofolate reductase, homocysteine and thrombophilia].
Topics: Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Thrombophilia | 2002 |
Is diabetic hypercoagulability an acquired annexinopathy? Glycation of annexin II as a putative mechanism for impaired fibrinolysis in diabetic patients.
Topics: Animals; Annexin A2; Clinical Trials, Phase III as Topic; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Fibrinolysis; Glycation End Products, Advanced; Glycosylation; Homocysteine; Hyperhomocysteinemia; Lipoprotein(a); Plasminogen; Risk Factors; Thrombophilia; Tissue Plasminogen Activator | 2002 |
Thrombophilic genotypes, natural anticoagulants, and plasma homocysteine in myeloproliferative disorders: relationship with splanchnic vein thrombosis and arterial disease.
Topics: Adult; Aged; Arterial Occlusive Diseases; Blood Coagulation Factor Inhibitors; Case-Control Studies; Comorbidity; Female; Genotype; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Myeloproliferative Disorders; Prevalence; Retrospective Studies; Splanchnic Circulation; Thrombophilia; Venous Thrombosis | 2003 |
Homocysteine is unlikely to be associated with the risk of thromboembolic complications in atrial fibrillation.
Topics: Adult; Age Factors; Aged; Atrial Fibrillation; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Risk; Thromboembolism; Thrombophilia; Ventricular Dysfunction, Left | 2003 |
Hyperhomocysteinemia and other newly recognized inherited coagulation disorders (factor V Leiden and prothrombin gene mutation) in patients with idiopathic cerebral vein thrombosis.
Topics: Adult; Antithrombin III; Cerebral Veins; Factor V; Female; Homocysteine; Humans; Hyperhomocysteinemia; Intracranial Thrombosis; Male; Point Mutation; Prevalence; Protein C; Protein S; Prothrombin; Risk Factors; Thrombophilia; Venous Thrombosis | 2004 |
Simultaneous central retinal vein and retinal artery branch occlusions in two patients with homocystinaemia.
Topics: Adult; Homocysteine; Humans; Male; Retinal Artery Occlusion; Retinal Vein Occlusion; Thrombophilia | 2004 |
Plasma homocysteine concentration is not associated with activated protein C resistance in patients investigated for hypercoagulability.
Topics: Activated Protein C Resistance; Adolescent; Adult; Aged; Child; Child, Preschool; Cohort Studies; Factor V; Female; Homocysteine; Humans; Infant; Infant, Newborn; Male; Middle Aged; Models, Biological; Protein C; Regression Analysis; Retrospective Studies; Thrombophilia | 2004 |
Age and homocysteine plasma levels are risk factors for thrombotic complications after ovarian stimulation.
Topics: Adult; Age Distribution; Cohort Studies; Factor V; Female; Homocysteine; Humans; Lupus Coagulation Inhibitor; Middle Aged; Ovulation Induction; Postoperative Complications; Risk Factors; Thrombophilia; Thrombosis | 2004 |
Hypercoagulable states in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Antithrombins; Carcinoma, Hepatocellular; Female; Homocysteine; Humans; Lipoprotein(a); Liver Neoplasms; Male; Middle Aged; Protein C; Protein S; Thrombophilia | 2004 |
Recurrent cerebral venous and peripheral arterial thrombosis.
Topics: Adolescent; Cerebral Veins; Female; Femoral Artery; Homocysteine; Humans; Magnetic Resonance Angiography; Thrombophilia; Thrombosis; Venous Thrombosis | 2004 |
A case of ischemic cerebral infarction associated with acute posterior multifocal placoid pigment epitheliopathy, CNS vasculitis, vitamin B(12) deficiency and homocysteinemia.
Topics: Adult; Brain Ischemia; Cerebral Infarction; Choroid Diseases; Homocysteine; Humans; Male; Pigment Epithelium of Eye; Thrombophilia; Vasculitis, Central Nervous System; Vitamin B 12 Deficiency | 2004 |
Unselected women with elevated levels of factor VIII:C or homocysteine are not at increased risk for obstetric complications.
Topics: Adolescent; Adult; Factor VIII; Family Health; Female; Homocysteine; Humans; Pregnancy; Pregnancy Complications; Risk; Thrombophilia | 2004 |
Combination of thrombophilia markers in acute myocardial infarction of the young.
Topics: Adult; Antithrombin III; Biomarkers; Coronary Angiography; Echocardiography; Electrophoresis, Polyacrylamide Gel; Factor V; Female; Fibrinogen; Homocysteine; Humans; Male; Myocardial Infarction; Point Mutation; Protein C; Risk Factors; Thrombophilia | 2004 |
[Homocystein and cardiovascular risk: is dosage useful?].
Topics: Adult; Coronary Artery Disease; DNA Mutational Analysis; Genetic Carrier Screening; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Myocardial Infarction; Protein S Deficiency; Prothrombin; Recurrence; Risk Factors; Thrombophilia | 2004 |
Diagnostic issues in thrombophilia: a laboratory scientist's view.
Topics: Antithrombins; Blood Coagulation Tests; Chemistry, Clinical; Female; Hematologic Tests; Hematology; Homocysteine; Humans; Male; Mutation; Pregnancy; Protein C; Protein S; Risk; Risk Factors; Thrombophilia; Thrombosis | 2005 |
Thrombophilic risk factors for symptomatic peripheral arterial disease.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Antiphospholipid; Arteriosclerosis; Factor V; Female; Homocysteine; Humans; Lipoprotein(a); Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Peripheral Vascular Diseases; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Prothrombin; Risk Factors; Thrombophilia | 2005 |
A genomewide exploration suggests a new candidate gene at chromosome 11q23 as the major determinant of plasma homocysteine levels: results from the GAIT project.
Topics: Chromosome Mapping; Chromosomes, Human, Pair 11; Gene Expression Regulation, Enzymologic; Genetic Linkage; Genetic Markers; Genetic Variation; Genome, Human; Haplotypes; Heterozygote; Homocysteine; Humans; Lod Score; Methyltransferases; Models, Biological; Nicotinamide N-Methyltransferase; Polymorphism, Single Nucleotide; Risk Factors; Spain; Thrombophilia | 2005 |
Cardiovascular and thrombophilic risk factors for idiopathic sudden sensorineural hearing loss.
Topics: Adult; Aged; Antibodies, Anticardiolipin; Antithrombins; Case-Control Studies; Factor V; Female; Hearing Loss, Sensorineural; Homocysteine; Humans; Hypercholesterolemia; Hyperhomocysteinemia; Lipoprotein(a); Lupus Coagulation Inhibitor; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Plasminogen Activator Inhibitor 1; Protein C; Protein S; Risk Factors; Thrombophilia; Time Factors | 2005 |
Potential risk of a common hereditary thrombophilia and adjuvant chemotherapy for low-stage breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Fatal Outcome; Female; Fluorouracil; Homocysteine; Humans; Methotrexate; Middle Aged; Mutation; Risk; Thrombophilia | 2005 |
PAI-1 and homocysteine, but not lipoprotein (a) and thrombophilic polymorphisms, are independently associated with the occurrence of major adverse cardiac events after successful coronary stenting.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Coronary Disease; Factor V; Female; Homocysteine; Humans; Lipoprotein(a); Male; Middle Aged; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Prothrombin; Recurrence; Regression Analysis; Risk Factors; Stents; Syndrome; Thrombophilia | 2006 |
Thrombophilia testing in patients with venous thrombosis.
Topics: Blood Coagulation Factor Inhibitors; Factor V; Genetic Markers; Genetic Testing; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Prothrombin; Recurrence; Thrombophilia; Venous Thrombosis | 2005 |
Thrombophilias and stroke: diagnosis, treatment, and prognosis.
Topics: Anticoagulants; Cystathionine beta-Synthase; Factor V; Genetic Predisposition to Disease; Genetic Testing; Homocysteine; Humans; Hyperhomocysteinemia; Ischemic Attack, Transient; Methylenetetrahydrofolate Reductase (NADPH2); Platelet Activation; Platelet Aggregation; Polymorphism, Genetic; Prognosis; Protein S Deficiency; Prothrombin; Secondary Prevention; Stroke; Thrombophilia; Warfarin | 2005 |
Are homocysteine and MTHFR genotype polymorphism associated with arteriovenous fistula patency?
Topics: Arteriovenous Shunt, Surgical; Confounding Factors, Epidemiologic; Diet; Folic Acid; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Meta-Analysis as Topic; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic; Riboflavin; Risk Factors; Thrombophilia; Thrombosis | 2005 |
High levels of homocysteine, lipoprotein (a) and plasminogen activator inhibitor-1 are present in patients with abdominal aortic aneurysm.
Topics: Adult; Aged; Aged, 80 and over; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Biomarkers; Female; Homocysteine; Humans; Lipoprotein(a); Male; Middle Aged; Plasminogen Activator Inhibitor 1; Risk Factors; Thrombophilia | 2005 |
Hereditary thrombophilia in ethnic Omani patients.
Topics: Adolescent; Adult; Aged; Blood Coagulation Disorders, Inherited; Blood Proteins; Case-Control Studies; Child; DNA Mutational Analysis; Female; Homocysteine; Humans; Male; Middle Aged; Oman; Pulmonary Embolism; Thrombophilia; Thrombosis; Venous Thrombosis | 2006 |
Hyperhomocysteinemia and hypercoagulability in primary biliary cirrhosis.
Topics: Adult; Aged; Antithrombin III; Female; Folic Acid; Hemostasis; Homocysteine; Humans; Hyperhomocysteinemia; Liver Cirrhosis, Biliary; Male; Middle Aged; Peptide Hydrolases; Platelet Function Tests; Thrombomodulin; Thrombophilia; Thromboplastin; Vitamin B 12; Vitamin B 6 | 2006 |
[Thrombophilic factors in divers with undeserved decompression sickness].
Topics: Adult; Amino Acid Substitution; Antithrombin III; Decompression Sickness; Diving; Factor V; Factor VIII; Homocysteine; Humans; Male; Middle Aged; Mutation; Prothrombin; Thrombophilia | 2006 |
Thrombophilic risk factors and homocysteine levels in Behçet's disease in eastern Spain and their association with thrombotic events.
Topics: Adult; Behcet Syndrome; Case-Control Studies; Factor V; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Risk Factors; Spain; Thrombophilia; Thrombosis | 2006 |
[Homocysteinemia and thrombophilic factors in unexplained decompression sickness].
Topics: Adult; Decompression Sickness; Diving; Female; Folic Acid; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Single Nucleotide; Reference Values; Thrombophilia; Vitamin B 12 Deficiency | 2006 |
Role of hyperhomocystinemia in retinal vascular occlusive disease.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Case-Control Studies; Fasting; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Prevalence; Retinal Artery Occlusion; Retinal Vein Occlusion; Risk Factors; Thrombophilia | 2007 |
Cardiovascular and thrombophilic risk factors in patients with retinal artery occlusion.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Cross-Sectional Studies; Female; Homocysteine; Humans; Hypercholesterolemia; Lipoprotein(a); Male; Middle Aged; Odds Ratio; Pilot Projects; Polymorphism, Single Nucleotide; Retinal Artery Occlusion; Risk Factors; Smoking; Thrombophilia | 2007 |
Vitamin supplementation in the secondary prevention of venous thromboembolism: about the VITRO study.
Topics: Clinical Trials as Topic; Dietary Supplements; Homocysteine; Humans; Thrombophilia; Venous Thrombosis; Vitamins | 2007 |
Hyperhomocysteinemia and hypercoagulable state in carotid plaque evolution. Novel risk factors or coincidental risk predictors?
Topics: Aged; Antithrombin III; Blood Coagulation Factors; Carotid Artery Diseases; Female; Fibrinogen; Follow-Up Studies; Greece; Homocysteine; Humans; Hyperhomocysteinemia; Immunoassay; Incidence; Male; Prognosis; Protein C; Protein S; Receptors, Cell Surface; Retrospective Studies; Risk Factors; Thrombophilia; Ultrasonography, Doppler, Duplex | 2007 |
Hereditary thrombophilic risk factors and venous thromboembolism in Istanbul, Turkey: the role in different clinical manifestations of venous thromboembolism.
Topics: Adolescent; Adult; Aged; Factor V; Female; Homocysteine; Humans; Logistic Models; Male; Middle Aged; Mutation; Protein C; Prothrombin; Risk Factors; Thrombophilia; Venous Thromboembolism | 2008 |
Determinants and associations of homocysteine and prothrombotic risk factors in Kuwaiti patients with cerebrovascular accident.
Topics: Adult; Biomarkers; Case-Control Studies; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kuwait; Logistic Models; Male; Middle Aged; Risk Factors; Stroke; Thrombophilia | 2008 |
Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (Ala223Val MTHFR) in patients with inherited thrombophilic coagulation defects.
Topics: Adult; Aged; Antithrombin III; Antithrombin III Deficiency; Disease Susceptibility; Enzyme Activation; Factor V; Gene Frequency; Genotype; Homocysteine; Homocystine; Humans; Italy; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Protein C; Protein S Deficiency; Risk Factors; Thrombophilia | 1997 |
Homozygous cystathionine beta-synthase deficiency, combined with factor V Leiden or thermolabile methylenetetrahydrofolate reductase in the risk of venous thrombosis.
Topics: Adolescent; Adult; Child, Preschool; Cystathionine beta-Synthase; DNA Mutational Analysis; Factor V; Female; Homocysteine; Homocystinuria; Homozygote; Hot Temperature; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Protein Denaturation; Pulmonary Embolism; Risk Factors; Thrombophilia; Thrombophlebitis | 1998 |
A mnemonic for thrombophilia screening tests.
Topics: Homocysteine; Humans; Mass Screening; Thrombophilia | 1998 |
Frequency of factor V (FV) Leiden and C677T methylenetetrahydrofolate reductase (MTHFR) mutations in Colombians.
Topics: Adult; Colombia; Disease Susceptibility; Ethnicity; Factor V Deficiency; Gene Frequency; Genotype; Homocysteine; Humans; Indians, South American; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Prevalence; Risk Factors; Spain; Thrombophilia | 1998 |
Homocysteine, B vitamins, and vascular-access thrombosis in patients treated with hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Arteriovenous Shunt, Surgical; Blood Vessel Prosthesis; Erythrocytes; Female; Folic Acid; Genotype; Graft Occlusion, Vascular; Homocysteine; Humans; Male; Methylenetetrahydrofolate Dehydrogenase (NADP); Middle Aged; Pyridoxine; Renal Dialysis; Risk Factors; Thrombophilia; Vitamin B 12 | 1998 |
The results of diagnostic studies for thrombophilia in a large group of patients with a personal or family history of thrombosis.
Topics: Activated Protein C Resistance; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Child; Child, Preschool; Factor V; Genetic Predisposition to Disease; Homocysteine; Humans; Lupus Coagulation Inhibitor; Middle Aged; Mutation; Thrombophilia; Thrombophlebitis; Thrombosis | 1998 |
Homozygous G20210A prothrombin gene mutation without thromboembolic events: a case report.
Topics: 3' Untranslated Regions; Adult; Aged; Brain Ischemia; Female; Genetic Predisposition to Disease; Homocysteine; Homozygote; Humans; Male; Methionine; Middle Aged; Prothrombin; Risk Factors; Thrombophilia; Thrombophlebitis | 1998 |
Is the oral methionine loading test insensitive to the remethylation pathway of homocysteine?
Topics: Artifacts; Folic Acid Deficiency; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Methionine; Methylation; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Reproducibility of Results; Risk Factors; Thrombophilia | 1999 |
Homocysteine and arteriosclerosis: subclinical and clinical disease associations.
Topics: Adolescent; Adult; Animals; Arteriosclerosis; Child; Child, Preschool; Comorbidity; Folic Acid; Genetic Predisposition to Disease; Homocysteine; Homocystinuria; Humans; Hyperhomocysteinemia; Middle Aged; Prevalence; Primates; Risk Factors; Swine; Swine, Miniature; Thrombophilia | 1999 |
Familial thrombophilia and retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Antiphospholipid; Biomarkers; Female; Fibrinogen; Homocysteine; Humans; Male; Middle Aged; Pilot Projects; Prospective Studies; Retinal Vein Occlusion; Risk Factors; Thrombophilia | 2000 |
The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adolescent; Adult; Age of Onset; Aged; Amino Acid Substitution; Case-Control Studies; Fasting; Female; Folic Acid; Gene Frequency; Genetic Heterogeneity; Homocysteine; Humans; Hyperhomocysteinemia; Italy; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Nutritional Requirements; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Risk Factors; Sex Factors; Tetrahydrofolates; Thrombophilia; Thrombosis; Vitamin B 12; Vitamin B 12 Deficiency | 2000 |
A pilot study of the possible role of familial defects in anticoagulation as a cause for terminal limb reduction malformations.
Topics: Antibodies, Anticardiolipin; Antithrombin III; Factor V; Female; Homocysteine; Humans; Limb Deformities, Congenital; Male; Methylenetetrahydrofolate Reductase (NADPH2); Mothers; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Pilot Projects; Polymorphism, Genetic; Protein C; Protein S; Thrombophilia | 2000 |
Tissue factor and homocysteine levels in ischemic heart disease are associated with angiographically documented clinical recurrences after coronary angioplasty.
Topics: Adult; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Antithrombin III; Coronary Angiography; Female; Homocysteine; Humans; Hyperhomocysteinemia; Lipoproteins; Male; Middle Aged; Myocardial Ischemia; Peptide Hydrolases; Recurrence; Risk Factors; Thrombophilia; Thromboplastin; Vitamins | 2000 |
Markers of thrombophilia in retinal vein thrombosis.
Topics: Adult; Aged; Antithrombins; Biomarkers; Factor V; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Prevalence; Protein C; Protein S; Retinal Vein Occlusion; Retrospective Studies; Risk Factors; Thromboembolism; Thrombophilia | 2000 |
Hypercoagulable thrombophilic defects and hyperhomocysteinemia in patients with recurrent pregnancy loss.
Topics: Abortion, Habitual; Activated Protein C Resistance; Adult; Factor V; Female; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Oxidoreductases Acting on CH-NH Group Donors; Pregnancy; Thrombophilia | 2001 |
Importance of hyperhomocysteinemia as a risk factor for venous thromboembolism in a Taiwanese population. A case-control study.
Topics: Adult; Aged; Case-Control Studies; Factor V; Female; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Prevalence; Risk Factors; Taiwan; Thromboembolism; Thrombophilia; Venous Thrombosis | 2001 |
Terminal ileum resection is associated with higher plasma homocysteine levels in Crohn's disease.
Topics: Adult; Blood Sedimentation; Creatinine; Crohn Disease; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Ileum; Male; Thrombophilia; Vitamin B 12 | 2001 |
Comparative prevalence of antiphospholipid antibodies and thrombophilic genotypes in consecutive patients with venous thrombosis.
Topics: Adult; Age of Onset; Aged; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Female; Genotype; Homocysteine; Humans; Male; Prevalence; Risk Factors; Thrombophilia; Venous Thrombosis | 2001 |
Impact of plasma homocysteine and prothrombin G20210 A on primary antiphospholipid syndrome.
Topics: Adult; Age of Onset; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Case-Control Studies; Chi-Square Distribution; Female; Heterozygote; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Prevalence; Prothrombin; Thrombophilia; Thrombosis | 2001 |
Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years of age.
Topics: Activated Protein C Resistance; Adult; Blood Cell Count; Blood Glucose; Blood Pressure; Factor V; Female; Homocysteine; Humans; Intraocular Pressure; Lipids; Lupus Coagulation Inhibitor; Male; Middle Aged; Prospective Studies; Protein C; Protein S; Retinal Vein Occlusion; Retrospective Studies; Thrombophilia | 2002 |
Determination of total homocysteine in plasma: comparison of the Abbott IMx immunoassay with high performance liquid chromatography.
Topics: Adult; Chromatography, High Pressure Liquid; False Negative Reactions; Fasting; Female; Homocysteine; Humans; Hyperhomocysteinemia; Immunoassay; Male; Methionine; Middle Aged; Photochemistry; Reagent Kits, Diagnostic; Reproducibility of Results; Sensitivity and Specificity; Thrombophilia; Thrombosis | 2002 |